Newsmeme!
Discover News you didn't know existed
Hepatocyte
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Researchers Report Elevated Levels Of Tβ4 Levels Predict Patient Survival In Hepatitis B Virus-related Liver Failure
Published February 10, 2010, 1:42 am, Medical News Today
Regenerx Biopharmaceuticals, Inc. (NYSE Amex:RGN) announced that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity ...
Thymosin β4 exhibits potential as new therapeutic agent for liver failure due to chronic HBV infection
Published February 9, 2010, 3:31 am, News-Medical-Net
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the ...
Researchers Report Elevated Levels of T4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
Published February 8, 2010, 5:30 am, Business Wire via Yahoo! Finance
BETHESDA, Md.----REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure.
Health Highlights: Feb. 3, 2010
Published February 4, 2010, 1:32 pm, MedicineNet.com
Title: Health Highlights: Feb. 3, 2010 Category: Health News Created: 2/3/2010 12:10:00 PM Last Editorial Review: 2/4/2010
Health Highlights: Feb. 3, 2010
Published February 3, 2010, 9:03 am, HealthDay via Yahoo! News
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Press Release
Published February 3, 2010, 4:25 am, PharmiWeb
Celsis International Ltd. Posted on:03 Feb 10 BALTIMORE, February 2 /PRNewswire/ -- Celsis In Vitro, Inc. (Celsis IVT) announced today that it has filed apatent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd.,and Sekisui Medical Co. Ltd. in the United States District Court for theNorthern District of Illinois in Chicago.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |